These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25351213)

  • 1. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
    Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
    Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
    Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
    Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
    Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
    Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival.
    Lu G; Shan T; He S; Ren M; Zhu M; Hu Y; Lu X; Zhang D
    Oncol Rep; 2013 Nov; 30(5):2238-44. PubMed ID: 23970101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
    Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEK: A novel early screening and prognostic marker for breast cancer.
    Ying G; Wu Y
    Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.
    Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J
    J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
    Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
    Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
    Zhang Z; Meng G; Wang L; Ma Y; Guan Z
    Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
    Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
    Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma.
    Huang X; Qu P; Chen Y; Zhou X; Wu Y; Liu F; Wang D; Zhang J; An J
    Hum Pathol; 2014 Sep; 45(9):1944-50. PubMed ID: 25081539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.
    Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J
    J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.
    Zhang J; Tu K; Yang W; Li C; Yao Y; Zheng X; Liu Q
    Mol Med Rep; 2014 Aug; 10(2):749-54. PubMed ID: 24858621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
    Yu L; Zhang J; Guo X; Li Z; Zhang P
    Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
    Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
    Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.